Common Stock, Shares, Outstanding of TENAX THERAPEUTICS, INC. from 30 Apr 2011 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
TENAX THERAPEUTICS, INC. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 30 Apr 2011 to 31 Dec 2025.
  • TENAX THERAPEUTICS, INC. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 9,314,130, a 172% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

TENAX THERAPEUTICS, INC. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 9,314,130 +5,893,224 +172% 31 Dec 2025 10-K 10 Mar 2026 2025 FY
Q3 2025 5,907,233 +2,498,327 +73% 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 4,148,495 +2,190,250 +112% 30 Jun 2025 10-Q 13 Aug 2025 2025 Q2
Q1 2025 3,970,385 +2,012,140 +103% 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 3,420,906 +3,122,625 +1047% 31 Dec 2024 10-K 10 Mar 2026 2025 FY
Q3 2024 3,408,906 -20,453,528 -86% 30 Sep 2024 10-Q 13 Nov 2024 2024 Q3
Q2 2024 1,958,245 -21,904,189 -92% 30 Jun 2024 10-Q 13 Aug 2024 2024 Q2
Q1 2024 1,958,245 -19,819,189 -91% 31 Mar 2024 10-Q 14 May 2024 2024 Q1
Q4 2023 298,281 +269,633 +941% 31 Dec 2023 10-K 25 Mar 2025 2024 FY
Q3 2023 23,862,434 -6,117,749 -20% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 23,862,434 -1,344,480 -5.3% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 21,777,434 -3,429,480 -14% 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 28,648 -1,231,698 -98% 31 Dec 2022 10-K 28 Mar 2024 2023 FY
Q3 2022 29,980,183 +4,778,871 +19% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 25,206,914 -3,398 -0.01% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 25,206,914 +10,237,602 +68% 31 Mar 2022 10-Q 16 May 2022 2022 Q1
Q4 2021 1,260,346 -11,359,023 -90% 31 Dec 2021 10-K 31 Mar 2023 2022 FY
Q3 2021 25,201,312 +12,581,943 +100% 30 Sep 2021 10-Q 15 Nov 2021 2021 Q3
Q2 2021 25,210,312 +15,114,554 +150% 30 Jun 2021 10-Q 16 Aug 2021 2021 Q2
Q1 2021 14,969,312 +6,961,069 +87% 31 Mar 2021 10-Q 17 May 2021 2021 Q1
Q4 2020 12,619,369 +5,877,509 +87% 31 Dec 2020 10-K 29 Mar 2022 2021 FY
Q3 2020 12,619,369 +5,877,509 +87% 30 Sep 2020 10-Q 16 Nov 2020 2020 Q3
Q2 2020 10,095,758 +3,425,327 +51% 30 Jun 2020 10-Q 14 Aug 2020 2020 Q2
Q1 2020 8,008,243 +1,853,809 +30% 31 Mar 2020 10-Q 15 May 2020 2020 Q1
Q4 2019 6,741,860 +2,949,611 +78% 31 Dec 2019 10-K/A 16 Apr 2021 2020 FY
Q3 2019 6,741,860 +5,276,364 +360% 30 Sep 2019 10-Q 14 Nov 2019 2019 Q3
Q2 2019 6,670,431 +5,216,755 +359% 30 Jun 2019 10-Q 14 Aug 2019 2019 Q2
Q1 2019 6,154,434 +4,700,758 +323% 31 Mar 2019 10-Q 15 May 2019 2019 Q1
Q4 2018 3,792,249 +2,380,409 +169% 31 Dec 2018 10-K 30 Mar 2020 2019 FY
Q3 2018 1,465,496 -26,771,050 -95% 30 Sep 2018 10-Q 14 Nov 2018 2018 Q3
Q2 2018 1,453,676 -26,782,870 -95% 30 Jun 2018 10-Q 14 Aug 2018 2018 Q2
Q1 2018 1,453,676 -26,782,818 -95% 31 Mar 2018 10-Q 15 May 2018 2018 Q1
Q4 2017 1,411,840 +5,838 +0.42% 31 Dec 2017 10-K 01 Apr 2019 2018 FY
Q3 2017 28,236,546 +116,612 +0.42% 30 Sep 2017 10-Q 09 Nov 2017 2017 Q3
Q2 2017 28,236,546 +116,699 +0.42% 30 Jun 2017 10-Q 09 Aug 2017 2017 Q2
Q1 2017 28,236,494 +116,723 +0.42% 31 Mar 2017 10-Q 10 May 2017 2017 Q1
Q4 2016 1,406,002 -26,713,692 -95% 31 Dec 2016 10-K 02 Apr 2018 2017 FY
Q3 2016 28,119,934 +240 +0% 30 Sep 2016 10-Q 09 Nov 2016 2016 Q3
Q2 2016 28,119,847 +240 +0% 30 Jun 2016 10-Q 09 Aug 2016 2016 Q2
Q1 2016 28,119,771 +251 +0% 31 Mar 2016 10-Q 10 May 2016 2016 Q1
Q4 2015 28,119,694 +258 +0% 31 Dec 2015 10-K 16 Mar 2017 2016 FY
Q3 2015 28,119,694 +335 +0% 31 Oct 2015 10-Q 10 Dec 2015 2016 Q2
Q2 2015 28,119,607 +12,343 +0.04% 31 Jul 2015 10-Q 09 Sep 2015 2016 Q1
Q1 2015 28,119,520 +261,520 +0.94% 30 Apr 2015 10-KT 14 Mar 2016 2015 FY
Q4 2014 28,119,436 +21,305,143 +313% 31 Jan 2015 10-Q 17 Mar 2015 2015 Q3
Q3 2014 28,119,359 +21,305,066 +313% 31 Oct 2014 10-Q 15 Dec 2014 2015 Q2
Q2 2014 28,107,264 +25,045,074 +818% 31 Jul 2014 10-Q 15 Sep 2014 2015 Q1
Q1 2014 27,858,000 +25,927,922 +1343% 30 Apr 2014 10-KT 14 Mar 2016 2015 FY
Q4 2013 6,814,293 -26,836,206 -80% 31 Jan 2014 10-Q 17 Mar 2014 2014 Q3
Q3 2013 6,814,293 -26,085,607 -79% 31 Oct 2013 10-Q 17 Dec 2013 2014 Q2
Q2 2013 3,062,190 -28,004,272 -90% 31 Jul 2013 10-Q 17 Sep 2013 2014 Q1
Q1 2013 1,930,078 +459,188 +31% 30 Apr 2013 10-K 29 Jul 2014 2014 FY
Q4 2012 33,650,499 +5,415,032 +19% 31 Jan 2013 10-Q 18 Mar 2013 2013 Q3
Q3 2012 32,899,900 +9,042,229 +38% 31 Oct 2012 10-Q 14 Dec 2012 2013 Q2
Q2 2012 31,066,462 +7,666,377 +33% 31 Jul 2012 10-Q 19 Sep 2012 2013 Q1
Q1 2012 1,470,890 -21,922,417 -94% 30 Apr 2012 10-K 26 Jun 2013 2013 FY
Q4 2011 28,235,467 31 Jan 2012 10-Q 15 Mar 2012 2012 Q3
Q3 2011 23,857,671 31 Oct 2011 10-Q 15 Dec 2011 2012 Q2
Q2 2011 23,400,085 31 Jul 2011 10-Q 19 Sep 2011 2012 Q1
Q1 2011 23,393,307 30 Apr 2011 10-K 25 Jul 2012 2012 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.